Desteklenen Projeler
-
2024 - 2024 Tübitak 4008 Angelman Sendromu Sensiz AS'la
Diğer Resmi Kurumlarca Desteklenen Proje
AYÇA S., ORAK S. A., POLAT M., YAŞAR A., Öğüt N. G.(Yürütücü)
-
2023 - 2024 A Phase 2 B, Multicenter, 30 week, Prospective, Cross over, Double blind, Randomized, Placebo controlled Study Followed by a 52 Week Open label Extension Study to Evaluate the Efficacy and Safety of Basimglurant Adjunctive to Ongoing Anticonvulsive Therapy in Children, Adolescents, and Young Adults with Seizures Associated with Tuberous Sclerosis Complex